HR 3250 114th Congress House Health Child health Civil actions and liability Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Licensing and registrations Prescription drugs Retail and wholesale trades

DXM Abuse Prevention Act of 2015

Introduced: July 28, 2015 See on congress.gov

Everywhere this bill has been 11 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 8, 2016

Placed on the Union Calendar, Calendar No. 520.

Jul 8, 2016

Reported by the Committee on Energy and Commerce. H. Rept. 114-672.

Apr 27, 2016

Ordered to be Reported by Voice Vote.

Apr 27, 2016

Committee Consideration and Mark-up Session Held.

Apr 26, 2016

Committee Consideration and Mark-up Session Held.

Apr 25, 2016

Committee Consideration and Mark-up Session Held.

Apr 20, 2016

Forwarded by Subcommittee to Full Committee by Voice Vote .

Apr 20, 2016

Subcommittee Consideration and Mark-up Session Held.

Jul 31, 2015

Referred to the Subcommittee on Health.

Jul 28, 2015

Referred to the House Committee on Energy and Commerce.

Jul 28, 2015

Introduced in House

Plain-English summary Congressional Research Service

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

DXM Abuse Prevention Act of 2015

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit the sale of a drug containing dextromethorphan (DXM, a cough suppressant and drug of abuse) to an individual under age 18 unless the individual has a prescription or is actively enrolled in the military. Retailers selling DXM must implement a verification system to ensure compliance. Civil monetary penalties that escalate upon repeated violation are imposed.

(Sec. 3) Unfinished DXM may only be possessed by, distributed to, and received by persons registered with the Food and Drug Administration as producers of a drug or medical device or otherwise allowed to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients. Common carriers distributing unfinished DXM between authorized persons are exempted. Civil monetary penalties are imposed for possession and distribution violations.

What's happening now July 8, 2016

Placed on the Union Calendar, Calendar No. 520.

Committees of jurisdiction 2